DIA 2018 Call for Topics is Closed

Topic submissions are currently under review by the Annual Meeting Program Committee (AMPC). Accepted topics will assist with the content development and strategy for DIA 2018. Submission of a topic is not in any way related to a speaking role at DIA 2018.

A Call for Abstracts to solicit sessions and presentations at DIA 2018 will open on August 31, 2017 and close on September 23, 2017.

Learn more about the content development process for DIA 2018 and submission process for this Call and those in the future.

View Infographic

---

View tracks and included topics areas

• Regulatory

  Global and US Advertising and Promotional regulations and laws; Regulatory Operation best practices; Regulatory Intelligence; Developments in regulatory science; eSubmissions; regulatory document management, biosimilars, combination products, companion diagnostics; compliance

• Safety and Pharmacovigilance

  Safety/Pharmacovigilance best practices; guideline updates; Benefit-Risk Assessment; Risk-based monitoring; document management, biosimilars; post-market safety considerations; combination products; companion diagnostics; compliance; ICH(E); audit/inspection

• Clinical Trials and Clinical Operations

  Personalized medicine, gene editing, clinical trial recruitment and retention; patient engagement, site management; Specific Therapeutic Areas; endpoints/COA’s (Patient-reported outcome (PRO) measures, clinician-reported outcome (ClinRO) measures, observer-reported outcome (ObsRO) measures, and performance outcome (PerfO) measures; COA Compendium); Specific Therapeutic Areas; telemedicine, eHealth, mobile health, wearables, eHR, clinical trial diversity, collaborations; stem cells, regenerative therapies, gene therapies, etc., ICH(E); GCP, audit/inspection

• Data/ Data Standards

  Informatics, Data Standards and Standardization, Data Management, Data Quality, Data Systems; Data Integration, compliance, bioethics, security, data privacy, transparency, Big Data, data sources (eHR)

• Medical Affairs and Scientific Communication

  Medical Info; Medical Science Liaison; Medical Writing; Medical Affairs Roles throughout Product Lifecycle, Stakeholder Management, Advisory Boards, compliance

• Quality

  ICH Q, CMC, GMP, audit/inspection, compliance

• Statistics

  Adaptive Design; Bayesian Statistics; Informatics; bioinformatics; analytic standards, data visualization

• Project Management and Strategic Planning

  Portfolio management, Project management, Transformative partnerships, Funding; Global compliance, product life cycle planning, global commercialization considerations

• Preclinical Development and Early Phase Clinical Development

  Personalized Medicine; Gene Editing; Clinical trial data disclosure, Clinical trial data disclosure; Collaborations; bioethics; compliance; stem cells, regenerative therapies, gene therapies, etc.; ICH (S), study endpoints

• Value and Access

  Comparative Effectiveness Research, Health Technology Assessment, Real World Outcomes, Value Based Healthcare; Drug Pricing, Reimbursement and Access, Commercialization, Drug Product Life Cycle Considerations

Have Questions? Check out our FAQs on how to submit your abstract and more!

View Infographic

---

Registration Rates

Back to DIA 2018

Back to DIAglobal.org